Buys
Open market- Shares
- Avg price
- Total value
Daniel D. Long - SVP, Drug Discovery at Septerna, Inc.
Issuer-level insider activity
- Role
- SVP, Drug Discovery
- Issuer ticker
- SEPN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Daniel D. Long in Septerna, Inc.
Sells
Open market- Shares
- -21,834
- Avg price
- $32.53
- Total value
- -$710,333
Net
Past year- Shares
- -21,834
- Share %
- -100%
- Total value
- -$710,333
Reported holdings for Daniel D. Long in Septerna, Inc.
Form 4 holding
SVP, Drug Discovery
Septerna, Inc.
- Security class
- Common Stock
- Shares / value
- 96,412
- Estimated value
- $3,356,497
- Report date
- 01 Jul 2026
- Price
- $34.81
- Ownership
- Direct
Form 4 holding
SVP, Drug Discovery
Septerna, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 7,043
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Daniel D. Long in Septerna, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.